Aristides Capital’s Labcorp LH Stock Holding History

Aristides Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,889	Closed	-$205K	–	147
2020 Q1	$205K	Sell	1,889 -2,490	-57%	-$359K	0.15%	124
2019 Q4	$636K	Buy	+4,379	New	+$632K	0.49%	70

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Aristides Capital's LH Position: Q2 2020 in Review

Aristides Capital sold out of Labcorp (LH) in Q2 2020, closing a stake of 1,889 shares — an estimated $205K sold.

Aristides Capital first reported a position in LH in Q4 2019 and held it in 2 quarters. The position peaked at $636K in Q4 2019. 798 funds tracked by Wall St. Rank hold LH as of Q2 2020.

Aristides Capital reported no remaining Labcorp position as of Q2 2020 after selling out during the quarter.
Aristides Capital sold 1,889 Labcorp shares in Q2 2020, an estimated $205K.
Aristides Capital first reported a position in Labcorp in Q4 2019 and held it in 2 quarters.
Aristides Capital's Labcorp position peaked at $636K in Q4 2019.
798 funds tracked by Wall St. Rank held Labcorp as of Q2 2020.

Based on Aristides Capital's 13F filing for Q2 2020, filed 14 Aug 2020.